[HTML][HTML] Клинические рекомендации ОССН-РКО-РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН) …
ВЮ Мареев, ИВ Фомин, ФТ Агеев, ЮЛ Беграмбекова… - Кардиология, 2018 - lib.ossn.ru
1–«МНОЦ МГУ им. МВ Ломоносова», 119192, Москва, Ломоносовский пр-кт, д. 27, корп.
10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …
10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
The coexistence of type 2 diabetes mellitus (T2DM) and heart failure (HF), either with
reduced (HFrEF) or preserved ejection fraction (HFpEF), is frequent (30–40% of patients) …
reduced (HFrEF) or preserved ejection fraction (HFpEF), is frequent (30–40% of patients) …
[HTML][HTML] Russian heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: chronic (CHF) …
VY Mareev, IV Fomin, FT Ageev, YL Begrambekova… - Kardiologiia, 2018 - lib.ossn.ru
РЕКОМЕНДАЦИИ, СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)
G Savarese, J Bodegard, A Norhammar… - European journal of …, 2021 - Wiley Online Library
Aims Use and dosing of guideline‐directed medical therapy (GDMT) in patients with heart
failure (HF) have been shown to be suboptimal. Among new users of GDMT in HF, we …
failure (HF) have been shown to be suboptimal. Among new users of GDMT in HF, we …
[HTML][HTML] Sex and gender differences in myocarditis and dilated cardiomyopathy: an update
DL Fairweather, DJ Beetler, N Musigk… - Frontiers in …, 2023 - frontiersin.org
In the past decade there has been a growing interest in understanding sex and gender
differences in myocarditis and dilated cardiomyopathy (DCM), and the purpose of this review …
differences in myocarditis and dilated cardiomyopathy (DCM), and the purpose of this review …
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study
Introduction Despite clear guidelines recommendations, most patients with heart failure and
reduced ejection–fraction (HFrEF) do not attain guideline-recommended target doses. We …
reduced ejection–fraction (HFrEF) do not attain guideline-recommended target doses. We …
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on …
2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice …
College of Cardiology Foundation/American Heart Association Task Force on Practice …
Accelerated and personalized therapy for heart failure with reduced ejection fraction
L Shen, PS Jhund, KF Docherty… - European Heart …, 2022 - academic.oup.com
Aims Previously, guidelines recommended initiating therapy in patients with heart failure
and reduced ejection fraction (HFrEF) in a sequence that follows the chronological order in …
and reduced ejection fraction (HFrEF) in a sequence that follows the chronological order in …
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
KF Docherty, PS Jhund, SE Inzucchi… - European heart …, 2020 - academic.oup.com
Abstract Aims In the DAPA-HF trial, the SGLT2 inhibitor dapagliflozin reduced the risk of
worsening heart failure (HF) and death in patients with HF and reduced ejection fraction. We …
worsening heart failure (HF) and death in patients with HF and reduced ejection fraction. We …